Federico Perfetto

5.2k total citations
143 papers, 2.6k citations indexed

About

Federico Perfetto is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, Federico Perfetto has authored 143 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 41 papers in Cardiology and Cardiovascular Medicine and 33 papers in Nephrology. Recurrent topics in Federico Perfetto's work include Amyloidosis: Diagnosis, Treatment, Outcomes (75 papers), Parathyroid Disorders and Treatments (30 papers) and Circadian rhythm and melatonin (28 papers). Federico Perfetto is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (75 papers), Parathyroid Disorders and Treatments (30 papers) and Circadian rhythm and melatonin (28 papers). Federico Perfetto collaborates with scholars based in Italy, United States and Japan. Federico Perfetto's co-authors include Francesco Cappelli, Roberto Tarquini, B Tarquini, Franz Halberg, Germaine Cornélissen, Alberto Moggi Pignone, Stefano Perlini, Claudio Rapezzi, Franco Bergesio and Carlo Di Mario and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Federico Perfetto

136 papers receiving 2.6k citations

Peers

Federico Perfetto
William van’t Hoff United Kingdom
Federico Perfetto
Citations per year, relative to Federico Perfetto Federico Perfetto (= 1×) peers William van’t Hoff

Countries citing papers authored by Federico Perfetto

Since Specialization
Citations

This map shows the geographic impact of Federico Perfetto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Perfetto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Perfetto more than expected).

Fields of papers citing papers by Federico Perfetto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Perfetto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Perfetto. The network helps show where Federico Perfetto may publish in the future.

Co-authorship network of co-authors of Federico Perfetto

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Perfetto. A scholar is included among the top collaborators of Federico Perfetto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Perfetto. Federico Perfetto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Argirò, Alessia, Costanza Bürgisser, Francesco Fattirolli, et al.. (2023). Serial Changes in Cardiopulmonary Exercise Testing Parameters in Untreated Patients With Transthyretin Cardiac Amyloidosis. Canadian Journal of Cardiology. 40(3). 364–369. 3 indexed citations
2.
Smorti, Martina, Lucia Ponti, Alessia Argirò, et al.. (2023). Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis. Frontiers in Psychology. 13. 1066224–1066224. 8 indexed citations
3.
Argirò, Alessia, Samuele Baldasseroni, Carlo Fumagalli, et al.. (2022). Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis. Internal and Emergency Medicine. 18(2). 585–593. 5 indexed citations
4.
Perfetto, Federico, Mattia Zampieri, Carlo Fumagalli, Marco Allinovi, & Francesco Cappelli. (2022). Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist. Internal and Emergency Medicine. 17(4). 957–969. 15 indexed citations
5.
Perfetto, Federico, Mattia Zampieri, Giulia Bandini, et al.. (2022). Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease. Biomedicines. 10(12). 3226–3226. 6 indexed citations
6.
Stefano, Vincenzo Di, Luca Gentile, Pietro Guaraldi, et al.. (2022). Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran. Pharmacogenomics and Personalized Medicine. Volume 15. 499–514. 15 indexed citations
7.
Argirò, Alessia, Annamaria Del Franco, Marco Allinovi, et al.. (2022). Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not. Biomedicines. 10(11). 2888–2888. 9 indexed citations
8.
Emdin, Michele, Federico Perfetto, Alberto Aimo, et al.. (2021). Percorso clinico-assistenziale in rete per la diagnosi e la gestione del paziente con amiloidosi cardiaca. Documento di consenso ANMCO Toscana e SIC Tosco-Umbra. Giornale italiano di cardiologia. 22(8). 621–634.
9.
Zampieri, Mattia, Marco Allinovi, Iacopo Olivotto, et al.. (2021). Ventricular tachyarrhythmias and sudden cardiac death in light‐chain amyloidosis: a clash of cardio‐toxicities?. British Journal of Haematology. 193(4). e27–e31. 5 indexed citations
10.
Fumagalli, Carlo, Mattia Zampieri, Federico Perfetto, et al.. (2021). Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis. Mayo Clinic Proceedings. 96(8). 2185–2191. 21 indexed citations
11.
Emdin, Michele, Alberto Aimo, Claudio Rapezzi, et al.. (2019). Treatment of cardiac transthyretin amyloidosis: an update. European Heart Journal. 40(45). 3699–3706. 111 indexed citations
12.
Aquaro, Giovanni Donato, Nicola Riccardo Pugliese, Federico Perfetto, et al.. (2014). Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis. International journal of cardiac imaging. 30(6). 1105–1115. 21 indexed citations
13.
Smorti, Martina, Francesco Cappelli, Franco Bergesio, & Federico Perfetto. (2012). Anxiety and depression among AL amyloidosis patients: the role of cardiac symptoms. Amyloid. 19(3). 123–128. 11 indexed citations
14.
Cornélissen, Germaine, et al.. (2009). Investigation of Solar about 5-Month Cycle in Human Circulating Melatonin: Signature of Weather in Extraterrestrial Space?. 4. 55–59. 2 indexed citations
15.
Tarquini, Roberto, Federico Perfetto, Franco Bergesio, et al.. (2007). A new ATTR Phe64Ile mutation with late-onset multiorgan involvement. Amyloid. 14(4). 289–292. 1 indexed citations
16.
Guiducci, Serena, Angela Del Rosso, Marina Cinelli, et al.. (2005). Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis. Arthritis Research & Therapy. 7(6). R1244–53. 9 indexed citations
17.
Cornélissen, Germaine, Franz Halberg, Earl E. Bakken, et al.. (2004). 100 or 30 years after Janeway or Bartter, Healthwatch helps avoid ‘flying blind’. Biomedicine & Pharmacotherapy. 58. S69–S86. 21 indexed citations
18.
Halberg, Franz, Chen‐Huan Chen, George Katinas, et al.. (2000). Chronobiology: Time Structures, Chronomes, Gauge Aging, Disease Risk Syndromes and the Cosmos. 3(1). 67–90. 16 indexed citations
19.
Halberg, Franz, Germaine Cornélissen, Othild Schwartzkopff, et al.. (1999). The Story Behind: Chronorisk/Circadian-Circannual (Macey, 1994).. PubMed. 20(1-2). 102–104. 1 indexed citations
20.
Halberg, Franz, et al.. (1999). Chronorisk/Circadian-Circannual (Macey, 1994). 20. 102–104. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026